Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas

Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas

Ovarian cancer has the worst prognosis among gynecological cancers. In particular, clear cell and mucinous carcinomas are less sensitive to chemotherapy. The establishment of new therapies is necessary to improve the treatment outcomes for these carcinomas. In previous clinical studies, chemotherapy...

Full description

Bibliographic Details
Main Authors: Tadahiro Shoji, Shunsuke Tatsuki, Marina Abe, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba, Hiroaki Itamochi
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
ovarian cancer
clear cell carcinoma
mucinous carcinoma
chemotherapy
clinical trial
Online Access:https://www.mdpi.com/2072-6694/13/23/6120

Internet

https://www.mdpi.com/2072-6694/13/23/6120

Similar Items